This report on the non-invasive prenatal testing (NIPT) market gives an all-inclusive view of the NIPT industry based on products and regional categories. The study provides market size and forecast (USD Mn) for its segments from 2014 to 2022 and respective CAGRs (value%) from 2016 to 2022, using 2015 as the base year. In addition, market dynamics such as drivers, challenges, prospects, and major commercial events are discussed in this report to evaluate the overall market trends.
Over the last decade, global non-invasive prenatal testing (NIPT) has shown healthy growth. The rise in the global average maternal age, coupled with the increasing incidence of Down syndrome in newborns, has boosted the market to a significant level. The market is expected to be driven by the growing demand for early and non-invasive fetal diagnosis in the coming years.
Over the past few years, the global non-invasive prenatal testing market has undergone phenomenal growth, with several commercially introduced tests. The rise in maternal age and the growing incidence of genetic abnormalities in newborns are the most significant drivers of this market. This report scrutinizes the major NIPT tests currently available on the market. Namely, MaterniT21 PLUS, BambniTest, informatic Prenatal Test, Harmony Prenatal Test, Non-invasive Fetal Trisomy (NIFTY) Test, verify, PrenaTest, Panorama Test, VisibiliT Test, and others.
Based on geographical distribution, the global non-invasive prenatal testing market is categorized into the following sub-markets:
North America
U.S.
Canada
Europe
U.K.
Germany
Europe as a whole
Asia-Pacific
Japan
China
Asia-Pacific as a whole
Africa and the Middle East
Latin America
In this study, the market size and forecast for the years 2014 through 2022 and the CAGRs for the years 2016 through 2022 are also given.
Along with the quantitative information sets, this report also includes market assessment tools such as attractive investment propositions, major commercial events, and fractal map analysis for competitive assessment of the global non-invasive prenatal testing market. Finally, this report concludes with a company profiles section highlighting key information about the major market players engaged in developing, manufacturing, distributing, and selling non-invasive prenatal tests in the international markets.
Frequently asked questions :
The market for Non-Invasive Prenatal Testing Market is expected to reach US$ 1,939.9 Mn By 2022.
The Non-Invasive Prenatal Testing Market is expected to see significant CAGR growth over the coming years, at 17.9%.
The report is forecasted from 2015-2022.
The base year of this report is 2021.
Ariosa Diagnostics, Inc., Berry Genomics Co., Ltd., BGI Diagnostics, Illumina, Inc.,are some of the major players in the global market.
